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Piebaldism is an autosomal dominant genetic disorder of pig-
mentation characterized by congenital patches of white skin 
and hair that lack melanocytes. Piebaldism results from mu-
tations of the KIT proto-oncogene, which encodes the ceJlu-
lar receptor transmembrane tyrosine kinase for mast/stem 
cell growth factor. Here we describe two novel KIT muta-
tions associated with human piebaldism. These amino acid 
Piebaldism is a rare autosomal dominant genetic disorder of melanocyte development characterized by white patches of skin and hair that completely lack pigment, located principally on the scalp, forehead, ventral chest and abdomen, and extremities [1- 3J. Melanocytes are 
absent from the regions of leukoderma [4,SJ, and piebaldism is 
thought to result from defective melanocyte proliferation or migra-
tion from the neural crest during development. In contrast to viti-
ligo, with which it is often confused, piebaldism is both congenital 
and non-progressive. Because of its distinctive ph~noty'pe, p~ebald­
ism has been known since at least anCient Greek times 16]. Piebald-
ism was one of the first genetic disorders for which a pedigree was 
presented [7], and sever~1 families have been reported that trace 
inheritance of the disorder over hundreds of years (reviewed in [2]). 
Etymologically, "pie" apparently refers to the variegated black-
and-white plumage pattern characteristic of the magpie, and "bald" 
derives from the Greek pha/iDs, "having a white spot." 
In mice, a disorder similar to human piebaldism, "dominant 
white spotting" (W), characterized by defects of pigmentation, he-
matopoiesis, and germ-cell development (reviewed in [8,9]), results 
from deletions or point mutations of the KIT proto-oncogene [10-
16]. KIT, originally identified as an oncogene in the HZ4-fclille 
sarcoma virus [17J, encodes the cell surface transmembrane receytor 
protein tyrosine kinase for the mast/stem cell growth factor [18-
21J. The KIT receptor polypeptide consists of a penta-repetitive 
extracellular ligand-binding domain, a short transmembrane do-
main, and a bipartite intracellular tyrosine kinase domain [22). On 
binding of growth factor ligand to the extracellular domain, the 
KIT receptor monomer undergoes dimerization within the cell 
membrane, activating the kinase and initiating the signal-transduc-
tion process (reviewed in [23,24]). 
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Abbreviation: SSCP, single-strand conformation polymorphism. 
substitutions, located in the most highly conserved sectiol1\ 
of the KIT kinase domain, would be expected to dominant\ 
negatively inhibit KIT-dependent signal transduction, reI 
suiting in aberrant melanocyte proliferation or migratio~ 
during embryologic development. ] Invest Dermatol1 01 :22 "\ 
25, 1993 
The human KIT gene consists of 21 exons spanning more than 3~ 
kbp of DNA [25] at chromosome segment 4q11-q12 [22,26]. Th~ 
observation of interstitial deletions of chromosome segment 4ql ~ 
in some patients with piebaldism [27 - 30J initially suggested that 
human piebaldism, like mouse dominant white spotting, migh\ 
result from defects of the KIT gene. This hypothesis was supporteq 
by the demonstration of complete deletion of the KIT gene in twq 
patients with piebaldism [31,32]. We [33-35J and others [36] hav~ 
recently described a variety of point mutations of the KIT gene i~ 
patients with piebaldism. Here we report two novel missense muta, 
tions in the tyrosine kinase domain of the KIT gene in two addi\ 
tional families with piebaldism. The human KIT gene mutatio~ 
closely parallel those of mouse and would be expected to dominant\ 
negatively disrupt function of the KIT receptor, resulting ulth 
mately in the aberrant embryologic distribution of melanocytes that 
is characteristic of piebaldism. 
MATEIUALS AND METHODS 
Description of Pro bands Family 1 is a large kindred from Cap~ 
Verde Island (Africa) in which piebaldism can be traced for at leas\ 
four generations. Proband 1 exhibited a large white forelock an~ 
extensive leukoderma of the forehead and abdomen, with numerous. 
hyperpigmented macules and cafe-au-Iait spots interspersed among 
and within the regions of hypopigmentation. A complete blood 
count was within normal limits. The proband's only child, a daugh, 
ter, also exhibited white forelock and extensive leukoderma of tbr 
abdomen, arms, and legs, with numerous interspersed hyperpig, 
mented macules. 
Family 2, in which piebaldism can be traced over three genera, 
tions, has previously been described in detail in the literature [37]: 
proband 2 is individual III -5 of that kindred. The piebald phenotyp~ 
in this family is also relatively severe, including white forelocks and 
extensive leukoderma of the forehead, chin, ventral trunk, and ex, 
trernities. Numerous hyperpigmented macules and cafe-au-lait spOil 
are interspersed within and among the regions of hypopigmentation. 
Polymerase Chain Reaction Amplification and Analysis of 
the Human KIT Gene The 21 exons of the human KIT gene 
and their flanking sequences [25] were amplified from genomi~ 
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Figure 1. SSCP /heteroduplex (HDX) analyses of KiT exon t 7. The SSCP 
and HDX patterns are indicated: lalle 1, proband t; lalle 2, unrelated normal 
person; lalle 3, proband 2; lane 4, affected sister of proband 2; lalle 5, affected 
daughter of proband 2. For reasons that are not apparent, the SSCP pattern of 
proband t was consistently faint . 
DNA of probands 1 and 2 and an unrelated, normally J:?igmented 
person by 35 cycles of the polymerase chain reaction [38) using 
oligonucleotide primers exactly as previously described [34,35). 
The amplified fragments were then screened for single-base 
changes by simultaneous single-strand conformation polymor-
phism (SSCP)jheteroduplex analyses, also exactly as described [35). 
Exon fragments that yielded clearly abnormal or suspicious patterns 
were independently reamplified in duplicate from genomic DNA 
and cloned in M13mp18, and at least six independent clones of each 
were subjected to DNA sequence analyses [39). 
Segregation Analysis A 277 -bp fragment containing KIT exon 
17 plus portions of the adjacent intervening sequences was polymer-
ase chain reaction amplified from DNA of the proband of family 2, 
her similarly affected daughter and sister, and an unrelated normally 
pigmented person. The amplification products were subjected to 
SSCP jheteroduplex analysis, as described above, and scored for the 
aberrant or the normal exon 17 pattern. 
RESULTS 
Proband of Family 1 is Heterozygous for a Missense Substi-
tution at Codon 791 Combined SSCP jheteroduplex analysis of 
the 21 KIT exons amplified from DNAs of proband 1 and an unre-
lated normally pigmented person demonstrated abnormalities of 
both the SSCP and heteroduplex patterns for exon 17 of the pro-
band. As shown in Fig 1, exon 17 of the proband exhibited an 
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abnormal heteroduplex pattern. The SSCP pattern, although repro-
ducibly quite faint, was also abnormal. Analyses of the remainder of 
the KIT exons of the proband appeared normal (data not shown) . 
The exon 17 segment was independently reamplified from ge-
nomic DNA of proband 1 and cloned in M13mp18. As shown 
in Fig 2A, DNA sequence analyses demonstrated that she is heter-
ozygous for a single-base substitution within codon 791, within 
the intracellular tyrosine kinase domain. This substirution, 
AGA -+ GGA, results in the substitution of glycine for the normal 
arginine at this site. 
Proband of Family 2 is Heterozygous for a Missense Substi-
tution at Codon 812 Combined SSCP jheteroduplex analysis of 
the 21 KIT exons amplified from DNAs of proband 2 and an unre-
lated normally pigmented person also demonstrated an aberrant 
pattern for exon 17 of this proband. As shown in Fig 1, exon 17 of 
the proband exhibited abnormalities of both the SSCP and hetero-
duplex patterns. Analyses of the remainder of the KIT exons of the 
proband appeared normal (data not shown). 
The exon 17 segment was independently reamplified from ge-
nomic DNA of proband 1 and cloned in M13mp18. As shown 
in Fig 2B, DNA sequence analyses demonstrated that she is heter-
ozygous for a single-base substitution within codon 812, within 
the intracellular tyrosine kinase domain. This substirution, 
GGT -+ GTT, results in the substitution of valine for the normal 
glycine at this site. 
SSCP jheteroduplex analysis of KIT exon 17 fragments polymer-
ase chain reaction amplified from DNA of the proband's similarly 
affected daughter and sister likewise demonstrated the same 
aberrant patterns as the proband (Fig 1). Thus, the codon 812 muta-
tion appears to co-segregate with the piebald phenotype in this 
family. 
DISCUSSION 
We used the approach of polymerase chain reaction amplification, 
rapid screening by combined SSCP jheteroduplex analysis, and sub-
sequent DNA sequence analysis to quickly and efficiently identify 
two novel mutations of the KIT gene in patients with piebaldism. 
Both are missense substitutions located within the intracellular tyro-
sine kinase domain of the 976-amino acid KIT polypeptide. 
Missense substitutions in the KIT tyrosine kinase domain inhibit 
function of the KIT receptor in a so-called dominant-negative man-
ner. Receptor homodimers composed of two mutant KIT polypep-
tides containing substitutions in the tyrosine kinase domain lack 
kinase activity. However, receptor heterodimers formed between a 
normal and a mutant KIT monomer also lack kinase activity [40-
43). Thus, KIT-dependent signal transduction is reduced by approx-
imately 75% in persons heterozygous for KIT kinase domain substi-
rutions, accounting for the autosomal dominant mode of 
inheritance associated with piebaldism. 
The codon 791 mutation of proband 1 is almost certainly patho-
logic. It is not a common polymorphism. We have not observed it in 
similar analyses of 37 other unrelated people. Furthermore, codon 
791 is located in the center of region Vlb of the highly conserved 
kinase domain, one of the two most highly conserved portions of 
the kinase domain. In fact, the amino acid sequence of codons 790-
792, His-Arg-Asp, is absolutely invariant among all known protein 
tyrosine kinases (reviewed in [44)) , and the substitution of neutral 
glycine for basic arginine at the central position of this triplet would 
almost certainly be deleterious. Of interest, this human KIT gene 
mutation is only two amino acids away from the mouse W42 muta-
tion, at codon 790 [14) (note that the codon numbering of the 
human and mOllse KIT polypeptides are not precisely the same), an 
additional indication that this region is particularly important for 
function of the IUT receptor kinase. 
Similarly, the codon 812 mutation of proband 2 is also almost 
certainly pathologic. It is also not a common polymorphism, not 
occurring among 37 other unrelated persons. This mutation co-seg-
regates with the piebald phenotype in first-degree relatives of the 
proband. Codon 812 is located in the center of region VII of the 
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Figure 2. KIT exon 17 sequences in probands 1 and 2. A) Proband 1; sequences in the region of codon 791 . B) Prob:lJ1d 2; sequences in the region of codoQ 
812, For both probands, both the normal and mutant alleles are show n, The sequences indicated arc of the coding strand. The abnormal codoll is indicated in 
each casc, 
highly conserved kinase domain, the second of the two most highly 
conserved portions of the kinase domain . In fact, the amino acid 
sequence of codons 810 - 812, As~-Phe-G}y, is.likewise a~so l ute!y 
invariant among all known protem tyrosme kmases (review ed m 
(44]), and the substitution of valine for the glycine normall y at 
codon 81 2 would almost certainly be deleterious. This human KIT 
gene mutation is only six amino acids aw ay from the mouse W f 
mutation, at codon 816 (16] (as noted above, the numbering of the 
human and mouse KIT codons is not identical). This further indi-
cates that this region is particularly important for function of the 
KIT receptor kinase. 
In fac t, all of the seven human KIT missense substitutions thus far 
observed in patients with piebaldism ((33 ,34,36]; this report; un-
published data) closely parallel the five known KIT missense substi-
tutions o f W mutant mice with "dominant white spotting." As 
noted above, th e codon 791 and 812 substitutions described her~ 
correspond closely to the mouse W42 and W f substitutions, respec, 
tively. W e previously reported human KIT substitutions at codon\ 
584 [34] and 664 [33] , w hich, respectively, correspond closely t (\ 
th e mouse W 37 [1 2,13] and W v (1 2] substitutions. Furthermore, 
Fleischman (36] recently reported a human KIT substitution a( 
codon 583 that precisely corresponds to the W 37 substitution at 
mouse, The reason for th e apparent close parallelism betwee~ 
human and mouse mutations is not yet clear. It may be that only ~ 
relatively limited number of sites in the KIT kinase domain ar~ 
critical for function or that only mutations at only a limited numbet 
of sites result in the piebald phenotype, the criterion by which thes~ 
patients (and mice) have been selected. Alternatively, this apparent 
parallelism may be merely a coincidence, the result of the relative I)' 
small number of mutations that have been identified to date. 
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